Study type: In vivo/preclinical · Status: Verified against declared source
Treatment of age-related visual impairment with a chemical sequence acting on mitochondria.
Disease models & mechanisms · 2022
Study scale: Since age itself contributes to untreatable visual decline, understanding the natural history and pathophysiology of visual aging has clinical relevance.
Abstract only: Open source record
Product or molecular entity relationships
- SS-31: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
A more likely explanation is that photopic and scotopic vision serves different purposes in mammals, and that spatial vision is more dependent on cone circuitry.
Methods
This study was neither designed to identify cellular mechanisms of aging, nor to determine how or where mitochondrial function and action are involved in the visual aging process and its remediation.
Scale or participants
Since age itself contributes to untreatable visual decline, understanding the natural history and pathophysiology of visual aging has clinical relevance.
Key findings
Age-related visual decline and disease due to neural dysfunction are major sources of disability that have resisted effective treatment.
Limitations and uncertainty
Visual decline related to normal aging contributes to disability and reduces health span (Owsley, 2011, 2016).
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.